MBCOF
Price
$0.08
Change
+$0.01 (+14.29%)
Updated
Jun 3 closing price
Capitalization
3.43M
ZEOX
Price
$1.87
Change
-$0.13 (-6.50%)
Updated
Jun 3 closing price
Capitalization
12.06M
Interact to see
Advertisement

MBCOF vs ZEOX

Header iconMBCOF vs ZEOX Comparison
Open Charts MBCOF vs ZEOXBanner chart's image
MARVEL BIOSCIENCES
Price$0.08
Change+$0.01 (+14.29%)
Volume$436
Capitalization3.43M
Zeo ScientifiX
Price$1.87
Change-$0.13 (-6.50%)
Volume$4.4K
Capitalization12.06M
MBCOF vs ZEOX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MBCOF vs. ZEOX commentary
Jun 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MBCOF is a Hold and ZEOX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 04, 2025
Stock price -- (MBCOF: $0.08 vs. ZEOX: $1.87)
Brand notoriety: MBCOF and ZEOX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MBCOF: 1% vs. ZEOX: 70%
Market capitalization -- MBCOF: $3.43M vs. ZEOX: $12.06M
MBCOF [@Biotechnology] is valued at $3.43M. ZEOX’s [@Biotechnology] market capitalization is $12.06M. The market cap for tickers in the [@Biotechnology] industry ranges from $321.16B to $0. The average market capitalization across the [@Biotechnology] industry is $2.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MBCOF’s FA Score shows that 1 FA rating(s) are green whileZEOX’s FA Score has 1 green FA rating(s).

  • MBCOF’s FA Score: 1 green, 4 red.
  • ZEOX’s FA Score: 1 green, 4 red.
According to our system of comparison, MBCOF is a better buy in the long-term than ZEOX.

Price Growth

MBCOF (@Biotechnology) experienced а +55.62% price change this week, while ZEOX (@Biotechnology) price change was -1.06% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.17%. For the same industry, the average monthly price growth was +4.97%, and the average quarterly price growth was -2.13%.

Industries' Descriptions

@Biotechnology (+6.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

FUNDAMENTALS
Fundamentals
ZEOX($12.1M) has a higher market cap than MBCOF($3.43M). MBCOF YTD gains are higher at: 10.504 vs. ZEOX (-39.871). MBCOF has higher annual earnings (EBITDA): -2.02M vs. ZEOX (-4.75M). ZEOX has more cash in the bank: 720K vs. MBCOF (59.5K). ZEOX has less debt than MBCOF: ZEOX (697K) vs MBCOF (1.71M). ZEOX has higher revenues than MBCOF: ZEOX (4.56M) vs MBCOF (0).
MBCOFZEOXMBCOF / ZEOX
Capitalization3.43M12.1M28%
EBITDA-2.02M-4.75M42%
Gain YTD10.504-39.871-26%
P/E RatioN/AN/A-
Revenue04.56M-
Total Cash59.5K720K8%
Total Debt1.71M697K245%
FUNDAMENTALS RATINGS
ZEOX: Fundamental Ratings
ZEOX
OUTLOOK RATING
1..100
54
VALUATION
overvalued / fair valued / undervalued
1..100
7
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JSVDX14.420.23
+1.62%
Janus Henderson Small-Mid Cap Value D
JVTIX81.290.91
+1.13%
Janus Henderson Venture I
TRVLX46.35N/A
N/A
T. Rowe Price Value
FVIFX33.31N/A
N/A
Fidelity Advisor Value I
SMECX8.35N/A
N/A
Invesco Small Cap Equity C

MBCOF and

Correlation & Price change

A.I.dvisor tells us that MBCOF and XENE have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MBCOF and XENE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MBCOF
1D Price
Change %
MBCOF100%
+12.71%
XENE - MBCOF
20%
Poorly correlated
+2.16%
AWKNF - MBCOF
20%
Poorly correlated
N/A
BSFAF - MBCOF
8%
Poorly correlated
N/A
ZEOX - MBCOF
6%
Poorly correlated
-6.50%
ATYR - MBCOF
5%
Poorly correlated
+13.47%
More

ZEOX and

Correlation & Price change

A.I.dvisor tells us that ZEOX and QURE have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ZEOX and QURE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZEOX
1D Price
Change %
ZEOX100%
-6.50%
QURE - ZEOX
21%
Poorly correlated
+4.66%
QTTB - ZEOX
14%
Poorly correlated
+4.92%
LENZ - ZEOX
10%
Poorly correlated
+2.09%
LIANY - ZEOX
9%
Poorly correlated
+2.43%
SER - ZEOX
9%
Poorly correlated
-0.08%
More